REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 86 filers reported holding REVANCE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 1.69 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,174,708 | -47.8% | 457,085 | 0.0% | 0.38% | -41.3% |
Q1 2024 | $2,248,858 | -44.0% | 457,085 | 0.0% | 0.65% | -34.4% |
Q4 2023 | $4,017,777 | -23.4% | 457,085 | 0.0% | 0.99% | -78.5% |
Q3 2023 | $5,242,765 | -54.7% | 457,085 | 0.0% | 4.62% | -47.2% |
Q2 2023 | $11,568,821 | -21.4% | 457,085 | 0.0% | 8.76% | +2.8% |
Q1 2023 | $14,722,708 | +74.5% | 457,085 | 0.0% | 8.52% | +81.1% |
Q4 2022 | $8,437,789 | -31.6% | 457,085 | 0.0% | 4.70% | -7.7% |
Q3 2022 | $12,341,000 | +95.4% | 457,085 | 0.0% | 5.10% | +95.3% |
Q2 2022 | $6,317,000 | -29.1% | 457,085 | 0.0% | 2.61% | +21.2% |
Q1 2022 | $8,913,000 | +19.5% | 457,085 | 0.0% | 2.16% | +28.4% |
Q4 2021 | $7,460,000 | -43.3% | 457,085 | -3.3% | 1.68% | -42.6% |
Q3 2021 | $13,166,000 | -64.7% | 472,590 | -64.6% | 2.92% | -46.9% |
Q2 2021 | $37,277,000 | -51.7% | 1,333,692 | -51.7% | 5.51% | -54.3% |
Q1 2021 | $77,141,000 | -18.6% | 2,759,950 | -17.4% | 12.06% | -50.9% |
Q4 2020 | $94,714,000 | +12.7% | 3,342,047 | 0.0% | 24.58% | -44.9% |
Q3 2020 | $84,019,000 | +2.9% | 3,342,047 | 0.0% | 44.64% | +11.5% |
Q2 2020 | $81,613,000 | +65.0% | 3,342,047 | 0.0% | 40.04% | +25.7% |
Q1 2020 | $49,462,000 | -8.8% | 3,342,047 | 0.0% | 31.84% | +25.9% |
Q4 2019 | $54,241,000 | +24.8% | 3,342,047 | 0.0% | 25.30% | -6.5% |
Q3 2019 | $43,447,000 | +0.2% | 3,342,047 | 0.0% | 27.06% | +8.3% |
Q2 2019 | $43,346,000 | -17.7% | 3,342,047 | 0.0% | 24.99% | -4.7% |
Q1 2019 | $52,671,000 | -42.6% | 3,342,047 | 0.0% | 26.22% | -28.2% |
Q4 2018 | $91,739,000 | +10.5% | 3,342,047 | 0.0% | 36.54% | +111.6% |
Q3 2018 | $83,050,000 | -9.5% | 3,342,047 | 0.0% | 17.27% | -18.9% |
Q2 2018 | $91,739,000 | -22.5% | 3,342,047 | -13.0% | 21.30% | -17.8% |
Q1 2018 | $118,335,000 | -13.8% | 3,842,047 | 0.0% | 25.90% | +4.3% |
Q4 2017 | $137,353,000 | +8.6% | 3,842,047 | -16.3% | 24.83% | +10.6% |
Q3 2017 | $126,511,000 | +4.4% | 4,592,047 | 0.0% | 22.44% | +2.4% |
Q2 2017 | $121,230,000 | +26.9% | 4,592,047 | 0.0% | 21.92% | +0.6% |
Q1 2017 | $95,515,000 | +0.5% | 4,592,047 | 0.0% | 21.79% | +0.5% |
Q4 2016 | $95,055,000 | +27.7% | 4,592,047 | 0.0% | 21.68% | +40.0% |
Q3 2016 | $74,437,000 | +19.2% | 4,592,047 | 0.0% | 15.49% | -1.6% |
Q2 2016 | $62,452,000 | -22.1% | 4,592,047 | 0.0% | 15.74% | -25.0% |
Q1 2016 | $80,177,000 | -48.9% | 4,592,047 | 0.0% | 20.98% | -26.9% |
Q4 2015 | $156,864,000 | +14.8% | 4,592,047 | 0.0% | 28.69% | +14.8% |
Q3 2015 | $136,659,000 | -6.9% | 4,592,047 | 0.0% | 24.98% | -5.8% |
Q2 2015 | $146,854,000 | +54.3% | 4,592,047 | 0.0% | 26.51% | +40.4% |
Q1 2015 | $95,193,000 | +22.4% | 4,592,047 | 0.0% | 18.88% | -22.2% |
Q4 2014 | $77,789,000 | -12.4% | 4,592,047 | 0.0% | 24.28% | -24.9% |
Q3 2014 | $88,764,000 | -43.1% | 4,592,047 | 0.0% | 32.32% | -0.5% |
Q2 2014 | $156,130,000 | +7.9% | 4,592,047 | 0.0% | 32.47% | -11.8% |
Q1 2014 | $144,649,000 | – | 4,592,047 | – | 36.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
PointState Capital LP | 438,200 | $11,568,000 | 0.13% |